Patents by Inventor Sandip P. Mehta

Sandip P. Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20220202782
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: March 15, 2022
    Publication date: June 30, 2022
    Inventors: Swati Nagar, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Sandeep Pal
  • Aqueous suspension suitable for oral administration
    Patent number: 11369567
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: June 28, 2022
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Sandip P. Mehta, Henil Alpeshbhai Patel, Jayanta Kumar Mandal
  • Liquid oral formulations for sildenafil
    Patent number: 11337979
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: May 24, 2022
    Assignee: LIQMEDS WORLDWIDE LIMITED
    Inventors: Jinal Pandya, Sandip P. Mehta, Manish Umrethia, Jayanta Kumar Mandal, Hiren Pansuriya
  • LIQUID ORAL FORMULATIONS FOR PDE V INHIBITORS
    Publication number: 20210393635
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: August 16, 2021
    Publication date: December 23, 2021
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • LIQUID ORAL FORMULATIONS FOR PDE V INHIBITORS
    Publication number: 20210369717
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: August 16, 2021
    Publication date: December 2, 2021
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • LIQUID ORAL FORMULATIONS FOR PDE V INHIBITORS
    Publication number: 20210052591
    Abstract: The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
    Type: Application
    Filed: December 24, 2018
    Publication date: February 25, 2021
    Inventors: Jinal PANDYA, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL, Hiren PANSURIYA
  • COMPOSITION COMPRISING BORTEZOMIB
    Publication number: 20190290718
    Abstract: The present invention provides a pharmaceutical composition of bortezomib. In particular, present invention provides ready-to-dilute injectable formulations comprising bortezomib, a non-aqueous solvent and a pH modifying or pH adjusting agent. Further, the present invention also relates to the process of manufacturing ready-to-dilute injectable formulations comprising bortezomib. The product prepared by following the process disclosed in the present application is stable at room temperature and possesses adequate shelf life (for example for 18-24 months).
    Type: Application
    Filed: June 10, 2019
    Publication date: September 26, 2019
    Applicant: FTF Pharma Private Limited
    Inventors: Jayanta Kumar Mandal, Sandip P. Mehta
  • ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PROCESS OF PREPARATION THEREOF
    Publication number: 20190209529
    Abstract: The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.
    Type: Application
    Filed: March 15, 2019
    Publication date: July 11, 2019
    Inventors: Swati NAGAR, Sandip P. MEHTA, Manish UMRETHIA, Jayanta Kumar MANDAL
  • Composition comprising bortezomib
    Patent number: 10314880
    Abstract: The present invention relates to ready to dilute injectable formulations of bortezomib comprising bortezomib, non-aqueous solvents enhancing the solubility and pH modifying agent.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: June 11, 2019
    Inventors: P. Kanteepan, Sagar Laxmanbhai Vekariya, Jayanta Kumar Mandal, Sandip P. Mehta
  • A NOVEL PHARMACEUTICAL COMPOSITION OF A LIPID LOWERING COMPOUND
    Publication number: 20190142741
    Abstract: The present invention provides liquid oral dosage form of lipid lowering agent suitable for oral administration to human or animals.
    Type: Application
    Filed: June 7, 2017
    Publication date: May 16, 2019
    Inventors: Sandip P. MEHTA, Henil Alpeshbhai PATEL, Jayanta Kumar MANDAL
  • COMPOSITION COMPRISING BORTEZOMIB
    Publication number: 20170035831
    Abstract: The present invention relates to ready to dilute injectable formulations of bortezomib comprising bortezomib, non-aqueous solvents enhancing the solubility and pH modifying agent.
    Type: Application
    Filed: August 5, 2016
    Publication date: February 9, 2017
    Applicant: FTF Pharma Private Limited
    Inventors: P. Kanteepan, Sagar Laxmanbhai Vekariya, Jayanta Kumar Mandal, Sandip P. Mehta